Panfeng Shang

13PUBLICATIONS
5CO-AUTHORS
Cancer cell biologyPredictive and prognostic markersMedical bacteriologyHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Sep 15, 2026
The MAZ-POLD1 Signaling Axis Drives Cisplatin Resistance in Bladder Cancer by Activating DNA Damage Repair.

|Aug 24, 2026
SERPINH1 derived from cancer-associated fibroblasts promotes epithelial-mesenchymal transition in clear cell renal cell carcinoma.

|Aug 09, 2026
Isolated Testicular Tuberculosis Mimicking a Testicular Tumor: A Case Report and Review of the Literature.

|Mar 14, 2026
Angiogenesis-Informed Preoperative CT Radiogenomics Predicts Overall Survival in Clear Cell Renal Cell Carcinoma: Development and External Validation.

Yanghuang Zheng, Yuelin Du, Zhongwei Ma

|Mar 02, 2026
A FOXO1-G6PC transcriptional axis restrains renal cell carcinoma progression: multi-omics, epigenetic, and mechanistic evidence.

Jieneng Wang, Bin Zhang, Hualan Ha

|Feb 13, 2026
TREM2 in Urological Malignancies and Benign Lesions: Mechanistic Convergence, Functional Heterogeneity, and Translational Perspectives: A Narrative Review.

Yu Dai, Yaqiang Feng, Cheng Wang

Pageof 3

Frequent Collaborators

2 joint publications

Qian Hou

2 joint publications

Biao Zhang

1 joint publications

Tian-Peng Zhan

1 joint publications

Xiao-Shan Li